Summary
Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures. Coloplast revises the guidance on organic growth and EBIT margin before spe
Source: The Manila Times
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
